Form 4: Teladoc Health Director Converts RSUs and Receives New Equity Grant

Teladoc Health, Inc. Director Catherine Jacobson converted previously granted restricted stock units into common stock and received a new grant of restricted stock units, as disclosed in a recent SEC Form 4 filing.

Summary

• Catherine Jacobson, a Director of Teladoc Health, Inc. (TDOC), converted 17,467 Restricted Stock Units (RSUs) into common stock on May 21, 2025.
• These 17,467 RSUs were originally granted on May 23, 2024, and vested in full on May 21, 2025.
• Following this conversion, Catherine Jacobson's direct beneficial ownership of Teladoc Health common stock increased to 37,867 shares.
• Additionally, on May 22, 2025, Ms. Jacobson was granted 28,986 new Restricted Stock Units.
• These new 28,986 RSUs will vest in full on the earlier of May 22, 2026, or the day immediately preceding Teladoc Health's 2026 annual meeting of stockholders.

Sentiment

Score: 7

Explanation: The filing reflects routine equity compensation for a director, indicating continued alignment of interests with shareholders through stock ownership, which is generally viewed as a neutral to slightly positive signal.

Positives

• Director Catherine Jacobson's beneficial ownership of Teladoc Health common stock increased to 37,867 shares following the conversion of previously vested Restricted Stock Units, aligning her interests with shareholders.
• The grant of 28,986 new Restricted Stock Units to a director indicates continued commitment to aligning management incentives with long-term shareholder value through equity compensation.

Future Outlook

The document primarily details past and future equity compensation vesting schedules for a director, without providing broader forward-looking statements on company performance or strategic guidance beyond these specific equity grants.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically related to director equity compensation. It does not provide information on broader industry trends or competitive landscape, focusing solely on the individual's stock ownership changes.

Stakeholder Impact

• Shareholders: The equity grants and conversions align the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term stock value.

Next Steps

• Vesting of 28,986 Restricted Stock Units on the earlier of May 22, 2026, or the day immediately preceding Teladoc Health's 2026 annual meeting of stockholders.

Key Dates

Recommendation

Keywords

Teladoc Health, TDOC, Form 4, SEC filing, insider transaction, restricted stock units, RSU, common stock, director compensation, equity grant